Keystone Financial Group »

Poseida Therapeutics I shares owned by Keystone Financial Group

Quarter-by-quarter ownership of Poseida Therapeutics I (PSTX) shares owned by Keystone Financial Group from 13F filings

Historical chart of Keystone Financial Group investment in Poseida Therapeutics I

Tip: Access up to 7 years of quarterly data

All positions including Poseida Therapeutics I held by Keystone Financial Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Poseida Therapeutics I by Keystone Financial Group

Quarter filed Position value Share count Share price at filing
2023-12-31 $50k 15k 3.36
2023-09-30 $36k 15k 2.38

More positions owned by Keystone Financial Group

SPDR S&P MF Closed and MF Open (SPY)
Spdr Portfolio MF Closed and MF Open (SPLG)
Apple Common Stock (AAPL)
Vanguard Total MF Closed and MF Open (VTI)
Microsoft Corp Common Stock (MSFT)
Spdr Portfolio MF Closed and MF Open (SPYG)
Spdr Portfolio MF Closed and MF Open (SPYV)
Vanguard S&p MF Closed and MF Open (VOO)
Jpmorgan Us MF Closed and MF Open (JQUA)
Vanguard Value MF Closed and MF Open (VTV)
Berkshire Hathaway Common Stock (BRK.B)
Berkshire Hathaway Common Stock (BRK.A)
Amazon Common Stock (AMZN)
Nvidia Corp Common Stock (NVDA)
Victoryshares Us MF Closed and MF Open (CFO)

View all positions for Keystone Financial Group

Top funds holding Poseida Therapeutics I

Pentwater Capital Management
Vanguard Group
Aisling Capital Management
William Blair $ Company
Millennium Management
Charles Schwab Investment Management
Dimensional Fund Advisors
Goldman Sachs Group
Jacobs Levy Equity Management
Connor, Clark & Lunn Investment Management
Point72 Asset Management
MCF Advisors
Bank of America Corporation
Bank of New York Mellon
Barclays

View all funds holding Poseida Therapeutics I